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Abstract
Background: Most women suffer pain following an episiotomy and oral non-steroidal anti-inflammatory drugs are commonly used
for pain relief. Due to the gastrointestinal side effects of oral drugs, it seems that women are more accepting of topical medications
for pain relief.
Objectives: Therefore, the aim of this study was to compare the effects of lidocaine and mefenamic acid on post-episiotomy pain.
Patients and Methods: This clinical trial was carried out in 2011. It involved sixty women with singleton pregnancy who were given
an episiotomy at 38 to 42 weeks of gestation. The participants were randomly divided into two groups. One group received 2% lido-
caine cream (n = 30), while the other group received 250 mg of mefenamic acid (n = 30). The data were collected via a questionnaire
and a visual analog scale. Pain intensity was compared from the first complaint by the mother and at 6, 12, and 24 hours after the
delivery in both groups. The data were analyzed using SPSS (version 16), the t-test, and the paired t-test, and a P value of less than
0.05 was considered significant.
Results: The mean intensity of pain at the first compliant was 4.92± 1.9 in the lidocaine group and 4.90± 1.5 in the mefenamic acid
group, and the difference was not statistically significant (P = 0.20). Additionally, there was no significant difference in the mean
intensity of post-episiotomy pain between the two groups at 6 (P = 0.05), 12 (P = 0.36), and 24 (P = 0.98) hours after childbirth.
Conclusions: The effects of the lidocaine cream and mefenamic acid were similar in terms of the relief of post-episiotomy pain.
Lidocaine cream therefore represents a good alternative to mefenamic acid, which is commonly used to reduce pain following an
episiotomy, especially in women who are breastfeeding and who wish to avoid oral analgesic drugs being secreted in their milk.
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1. Background
Episiotomy is a common surgical procedure that is per-
formed during childbirth, although little evidence sup-
ports its routine use (1, 2). At least 35 45% of women
in developing countries who give birth in a hospital set-
ting are given an episiotomy (3). The perineal pain expe-
rienced due to receiving an episiotomy is severe during
the first few days after delivery, and it can lead to limi-
tations in movement and difficulties with urination and
defecation (2). Studies have also shown that episiotomy-
related pain may affect sexual contact (4). Different phar-
macological methods are commonly used for the relief of
perineal pain following an episiotomy, including aspirin-
codeine, acetaminophen-codeine, sodium diclofenac, and
non-steroidal anti-inflammatory drugs (NSAIDS). The non-
medicinal methods applied for pain relief include cold
and heat, acupressure, acupuncture, relaxation, distrac-
tion, and music therapy (5). The use of oral analgesics is
common, although their adverse effects include constipa-
tion, nausea, abdominal pain, and dizziness, all of which
limit their use. Due to the adverse effects of oral analgesics,
topical pain relief methods have been considered, includ-
ing hot and cold compresses, topical anesthetic, and radi-
ation. Lidocaine gel is one of the local anesthetics used for
pain relief. It blocks the sensory neurons of neuronal mem-
branes by inhibiting sodium, thereby preventing the trans-
mission of nerve messages and the sensation of pain. In-
deed, 2% lidocaine gel influences the structure of the per-
ineal nerve through the skin or membrane (6). In obstet-
rics, lidocaine gel is used to anesthetize the perineum dur-
ing the second stage of labor, and its benefits include less
systemic absorption and increased ease of administration
(7). In terms of the effect of lidocaine on post-episiotomy
pain, previous studies have reported conflicting results.
For example, one study reported that the severity of the
perineal pain in the group that received lignocaine gel in
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the first 48 hours after childbirth was less than that in the
group that received a placebo (7). However, another study
reported opposite results (8).
Non-steroidal anti-inflammatory drugs are analgesic
agents that are commonly used worldwide, and their effec-
tiveness in the treatment of acute pain has previously been
studied (9). Such drugs inhibit the oxygenase cycle and re-
duce the production of prostaglandins (10). Their physio-
logical effects involve protecting the gastric mucosa, regu-
lating the renal blood flow, and setting the tone of the vas-
cular endothelium (11). They also play an important role
in inflammation, although the mechanism of this action
has not yet been fully explained (12). Mefenamic acid is
one of the NSAIDS used for the relief of pain following an
episiotomy. It is more commonly used in the treatment of
primary dysmenorrhea, headache, toothache, and postop-
erative pain. It has been suggested that mefenamic acid
should not be taken for more than seven days. The typical
adult dose is 500 mg three times a day, although the dose
is different for children. After ingestion, mefenamic acid
is rapidly absorbed and it has a short half-life of approxi-
mately 2 hours (9). A review of four studies that involved
a total of 842 people reported that the degree of pain ex-
perienced after receiving 500 mg of mefenamic acid was
reduced in 50% of patients, whereas the pain reduction
was 20% in the group that received a placebo (13). Little
research has previously been conducted comparing the ef-
fects of lidocaine and mefenamic acid in reducing the per-
ineal pain experienced after an episiotomy.
2. Objectives
Since no prior study has compared the effects of li-
docaine cream and mefenamic acid on post-episiotomy
pain in primiparous women, this study was carried out
to compare the impact of the two methods of pain re-
lief on episiotomy-related pain in a teaching hospital in
Shahrekord, Iran.
3. Patients and Methods
This study involved a randomized controlled trial that
was conducted from February 2011 to December 2011 at the
antenatal clinic and post-delivery ward of Hajar hospital, a
university hospital and referral center for obstetric care in
Shahrekord, Iran. Permission to conduct the study was re-
ceived from the deputy of research and the ethics board of
Shahrekord University of Medical Sciences (code of ethics:
90-4-9). The study also received a clinical trial code from
the Iranian registry of clinical trials (IRCT201104253078N7).
During the study period, a total of 420 women who gave
birth at Hajar hospital experienced perineal trauma dur-
ing childbirth that required repair. Some 280 of those
women gave written informed consent to take part in the
study and 118 of them were found to be potentially eligi-
ble to participate. Of those, 58 women were excluded from
the study, while 60 women who underwent a normal vagi-
nal delivery and mediolateral episiotomy, and who met
the inclusion criteria, were selected by convenience sam-
pling. They were randomly allocated into the two groups.
One group (n = 30) received 250 mg of mefenamic acid,
while the other group (n = 30) received 2% lidocaine cream
(Figure 1). The randomization was performed according to
a random number table. The exclusion criteria included
women who had a postpartum hemorrhage, manual re-
moval of the placenta, severe asthma, gastric or duodenal
ulcer, and preeclampsia. Women with a known sensitiv-
ity to non-steroidal anti-inflammatory drugs, a laceration
of the perineum, an episiotomy longer than 5 cm, and an
adverse reaction to local anesthetics were also excluded.
The participants received written and verbal information
about the study at 37 weeks at the antenatal clinic and
they were given the same information on admission to the
postnatal ward by the ward midwife. All participants who
agreed with the study procedures and volunteered to par-
ticipate signed the free and informed consent form. Nei-
ther the women nor the investigators could be blinded to
the purpose of the study, although the individual respon-
sible for data analysis was blinded.
After the birth and at the time of admission to the
post-delivery ward, the intensity of the perineal pain was
assessed by the ward midwife using a visual analog scale
(VAS) at the time of first complaint by the women and prior
to them taking the first dose of their allocated medica-
tion. Then, 250 mg of mefenamic acid was administered
to the patients in the first group, while the patients in the
second group received 5 ml of 2% lidocaine cream on the
episiotomy line. The topical lidocaine cream was manu-
factured by the Tehran Chemie Pharmaceutical Company
(Tehran, Iran) and each 100 g of the cream contained 2.5 g
of lidocaine and 2.5 g of prilocaine. The mefenamic acid
was manufactured by the Raha Pharmaceutical Company
(Esfahan, Iran). The drugs were available in the hospital
pharmacy. Socio demographic information was provided
by the patient records. The visual analog scale asked the
women to score their pain from 0 = no pain to 10 = worst
possible pain (5). The primary outcomes were pain scores
at 6, 12, and 24 hours after birth and with rest. The sec-
ondary outcomes relating to pain were the frequency of
use of the allocated medication, use of additional analge-
sia, time from birth to first analgesia, dosing intervals, and
any adverse effects of the therapeutic medications. The
data were analyzed using SPSS (version 16). The categori-
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Gave Birth at Hajar's Hospital and Had Perineal 
Trauma Requiring Reparing (n = 420) 
 
Eligible for Taking Part in the Trial (n = 118)  
Providing Meeting Inclusion Criteria (n = 60) 
 
Random Allocation 
 Mefenamic Acid Group (n = 30) 
Analysed (n = 30)  Analysed (n = 30) 
Excluded the Study Due to:
1.Not Experiencing the Perineal Pain (n = 28)
2. Postpartum Hemmorrhage (n = 6)
3. Manual Removal of Placenta (n = 3)
4. severe Asthma (n = 2)
5. Gastric or Duodenal Ulcer (n=3)
6. Preeclampsia (n = 4)
7. Sensitivity to Anti-inflammatory Drugs (n = 2)
8. laceration of Perineum(n = 6)
9. length of Episiotomy Larger than 5 cm (n = 3)
10. Adverse Reaction to a Local Anesthetics (n = 1)
Gave Written Informed Consent (n = 280)
Lidocaine Group (n = 30)
Figure 1. Flowchart of the Study Protocol
cal variables were compared using theχ2 and Fisher’s exact
tests, while the continuous variables as measured on the
visual analog scale were compared using the independent
samples t-test. A P value of less than 0.05 was considered
to be statistically significant with a confidence interval of
95%. The individual responsible for analyzing the data was
blinded to the treatment groups.
4. Results
The two groups were well balanced in terms of their
demographic characteristics upon entry into the study, as
well as their labor and birth outcomes (Table 1). The study
outcome data were available for 100% of the women at 6,
12, and 24 hours after birth. A comparison of the mean in-
tensity of pain in the two groups is presented in (Table 2),
which shows that there is no statistically significant differ-
ence in the intensity of pain at the point of first compliant
following rest between the two groups (P = 0.20). Addition-
ally, no significant difference in the intensity of pain at 6
hours after childbirth was found between the two groups
(P = 0.05). The mean intensity of the post-episiotomy pain
was also not significantly different at 12 hours after child-
birth between the two groups (P = 0.36). Further, the dif-
ference was still not significantly different at 24 hours after
childbirth between the two groups. There was no signifi-
cant difference in the incidence of using the medications
during the 24 hours after delivery (P = 0.98), receiving ad-
ditional analgesic for pain relief, and the time from birth to
the first additional analgesia (Table 3). No adverse effects of
the therapeutic drugs were reported in the two groups.
The mean birth weight was 3071± 439 g in the group
that received lidocaine and 3016± 419 g in the group that
received mefenamic acid, and the difference was not sig-
nificant (P = 0.62). No significant difference was found in
the Apgar score at 1 minute after birth and upon admission
to the neonatal intensive care unit (NICU). The mean fre-
quency of drug use was 3.20 ± 1.9 in the lidocaine group
and 3.22± 1.7 in the mefenamic acid group, and again the
difference was not significant (P = 0.40). No adverse effects
of the drugs were reported.
5. Discussion
The findings of the present study showed that both li-
docaine cream and mefenamic acid were able to reduce
the severity of post-episiotomy pain over time, and there
was no significant difference in the intensity of pain be-
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Table 1. Demographic Characteristics of the Participantsa
Group Treatment Lidocaine, n = 30 Mefenamic Acid, n
= 30
P Value
Demographic
characteristics
Age, y 23.6± 4.6 24.2± 3.8 0.56
Height, cm 160± 5.2 162± 4.4 0.05
Weight, kg 57.9± 11.4 57.9± 8.6 0.99
Parity 1.4± 0.5 1.6± 0.8 0.46
Abortion 0.3± 0.4 0.2± 0.6 0.47
Gestational age
based on LMP,
week
39.4± 0.59 39± 0.89 0.07
Gestational age
based on
sonography, week
39.8± 0.48 39.5± 1 0.004
Length of
episiotomy, cm
3.2± 0.8 3.6±0.9 0.10
aValues are expressed as mean± SD.
Table 2. Pain Intensity at the Time of First Complaint and 6, 12, And 24 Hours After
Birth in the Two Groupsa
Group Treatment Lidocaine Mefenamic Acid P Value
Time of assessing pain
At first complaint of
pain
4.92± 1.9 4.90± 1.5 0.20
6 hours after birth 3.26± 1.3 3.10± 1.6 0.05
12 hours after birth 2.26± 1.7 2.86± 1.4 0.36
24 hours after birth 1.46± 1.2 1.49± 1.2 0.98
aValues are expressed as mean± SD.
Table 3. Comparison of Additional Analgesia Prior to Discharge, Time From Birth to
First Additional Analgesia, and Frequency of Use of the Therapeutic Drugs Between
the Two Groupsa
Variables Lidocaine, n = 30 Mefenamic Acid, n
= 30
P Value
Additional
analgesia prior to
discharge
11 (36) 12 (40) 0.35
Time from birth
to first additional
analgesia (h)
5.2± 1.1 4.9± 0.9 0.19
Frequency of use
of therapeutic
drugs (24 h)
3 3 0.84
aValues are expressed as mean± SD or No. (%) of women.
tween the two groups. Only a limited number of studies
have previously been conducted to compare the effects of
two sedative pain following an episiotomy. In this regard,
a study conducted in Ireland reported mefenamic acid and
lignocaine to have similar effects on the severity of post-
episiotomy pain (14), which is consistent with our findings.
Delaram et al. cited Abedzadeh (5) when noting that lido-
caine gel reduced the intensity of pain at 6 and 12 hours af-
ter administration. Another study showed that lidocaine
cream was able to reduce the severity of pain after an epi-
siotomy within 15 minutes of delivery, although this ef-
fect was not present at 30, 60, and 90 minutes after birth
(15). Yet, in another study, although the recipients of lig-
nocaine gel reported less pain than the placebo recipients,
the difference was only significant at 48 hours after deliv-
ery (7). Further, a study reported that lidocaine gel and a
diclofenac suppository have the same effect on episiotomy
pain relief during the first day postpartum (16). Studies
that examined the effect of mefenamic acid on dysmen-
orrhea reported the drug to reduce the pain in primary
dysmenorrhea (17). In a study conducted with the aim of
reducing acute pain following surgery using mefenamic
acid, the recipients reported at least 50% pain reduction
with 500 mg of mefenamic acid after 6 hours, while this
rate was 4% for the placebo group (9). The need for an ad-
ditional analgesic was also lower in the group that received
mefenamic acid than in the placebo group (9). Another
study reported that the administration of 500 mg of mefe-
namic acid is effective in relieving moderate to severe pain
after surgery (13).
The mode of delivery (i.e., normal delivery, forceps, or
vacuum) can affect post-episiotomy pain; however, in the
present study there was no significant difference in the
mode of delivery between the two groups. A study from
Colombia reported that when forceps are used for delivery,
there is a greater need to use an analgesic to reduce pain af-
ter an episiotomy (18). The type of episiotomy can also be
effective in reducing pain. Since we only used a mediolat-
eral episiotomy in the present study, this confounder vari-
able did not affect the results.
Additionally, the effect of the analgesic drugs used
during labor and after giving birth could affect the out-
come of the study, although there was no significant dif-
ference between the two groups in this regard. Although
the present study found no significant difference between
the effects of lidocaine cream and mefenamic acid on
post-episiotomy pain and hence determined that lidocaine
cream is a good alternative to mefenamic acid, it should
be noted that some patients may prefer the oral form of
a drug to the local form (19). Although the study did not
report any adverse effects of the utilized drugs, the poten-
tial side effects of these drugs should still be noted and the
necessary care provided.
The strengths of the present study were the random as-
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signment of participants to the study groups and the mea-
suring of the side effects of the medications. The relatively
small sample size and the inability to follow the patients
and assess their pain intensity at 48 hours and during the
first week after delivery can be seen as limitations of the
present study.
5.1. Conclusion
The effects of lidocaine cream and mefenamic acid on
the relief of post-episiotomy pain were similar. Lidocaine
cream is therefore a good alternative to mefenamic acid,
which is commonly used to reduce pain following an epi-
siotomy, especially in women who are breastfeeding and
who want to avoid oral analgesic drugs being secreted in
their milk.
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